Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users

European Journal of Epidemiology

Volumn 15, Issue 1, 1999, Pages 1-4

  Soriano, Vicenç ^a,b   Garcia Samaniego J ^a   Valencia, E ^a   Rodriguez Rosado R ^a   Munoz F ^a   Gonzalez Lahoz J ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b NONE   (Spain)

Author keywords

Drug users; Hepatitis B; Hepatitis C; Human immunodeficiency virus (HIV); Liver; Natural history; Viral hepatitis

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CAUSE OF DEATH; CHRONIC LIVER DISEASE; DISEASE COURSE; DRUG ABUSE; FEMALE; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LIFE EXPECTANCY; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; VIRUS HEPATITIS;

HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS D, CHRONIC; HIV INFECTIONS; HOSPITALIZATION; HUMANS; RETROSPECTIVE STUDIES; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0344959600     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007506617734     Document Type: Article

References (20)

1. Moore R, Hidalgo J, Sugland B, Chaisson R. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 1412-1416.
2. Vella S, Giuliano M, Pezzotti P. Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. JAMA 1992; 267: 1232-1236.
3. Haverkos H, Lange W. Serious infections other than HIV among intravenous drug abusers. J Infect Dis 1990; 161: 894-902.
4. Sabin C, Phillips A, Elford J, Griffiths P, Janossy G, Lee C. The progression of HIV disease in a haemophiliac cohort followed for 12 years. Br J Haematol 1993; 83: 330-333.
5. Lee C, Sabin C, Phillips A, Elford J, Pasi J. Morbidity and mortality from transfusion-transmitted disease in haemophilia. Lancet 1995; 345: 1309.
6. Jover R, Gutiérrez A, Boix V, Portilla J. Mortality caused by chronic liver disease in HIV-infected patients. Med Clin (Barc) 1995; 105: 48.
7. Martin P, Di Bisceglie A, Kassianides C, Lisker-Melman M, Hoofnagle J. Rapidly progressive Non-A, Non-B hepatitis in patients with HIV infection. Gastroenterology 1989; 97: 1559-1561.
8. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haemophilia patients. Br J Haematol 1994; 87: 555-561.
9. Eyster M, Diamondstone L, Lien J, Ehmann W, Quan S, Goedert J. The natural history of hepatitis C virus (HCV) infection in multitransfused hemophiliacs: Effect of coinfection with HIV. J AIDS Hum Retrovirol 1993; 6: 602-610.
10. Sánchez-Quijano A, Andreu J, Gavilán F, et al. Influence of HIV type 1 infection on the natural course of chronic parenterally acquired hepatitis C. Eur J Clin Microbiol Infect Dis 1995; 14: 949-953.
11. Soriano V, García-Samaniego J, Bravo R, et al. Morbidity and mortality with chronic viral liver disease in HIV-infected patients. Med Clin (Barc) 1995; 104: 641-644.
12. Phillips A, Sabin C, Elford J, Bofill M, Janossy G, Lee C. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection. BMJ 1994; 309: 309-313.
13. Thomas D, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995; 74: 212-220.
14. De Pouplana M, Soriano V, García-Samaniego J, Enríquez A, Muñoz F, González-Lahoz J. More severe course of Delta hepatitis in HIV-infected patients. Genitourin Med 1995; 71: 132-133.
15. Soriano V, Valencia E, Alba A, et al. Changing spectrum of diseases in hospitalized patients with HIV infection. Med Clin (Barc) 1993; 101: 736-740.
16. Montaner J, Le T, Hogg R, et al. The changing spectrum of AIDS index diseases in Canada. AIDS 1994; 8: 693-696.
17. Soto B, Sánchez-Quijano A, Rodrigo L, et al. HIV infection modifies the natural history of chronic parenterally acquired hepatitis C with an unusually rapid progression to cirrhosis. A multicenter study on 547 patients. J Hepatol 1997; 26: 1-5.
18. Rodríguez-Rosado R, Gacía-Samaniego J, Soriano V. Hepatotoxicity after introduction of highly active antiretroviral therapy. AIDS 1998; 12: 1256.
19. Soriano V, García-Samaniego J, Bravo R, et al. Interferon alfa for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Clin Infect Dis 1996; 23: 585-591.
20. National Institutes of Health. Consensus Development Conference Panel Statement: Management of hepatitis C. Hepatology 1997; 26 (Suppl. 1): 2-10.